The Effect of Sugar Load in IBS Patients Depending on Sucrase-isomaltase Genes
NCT ID: NCT05688826
Last Updated: 2025-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2023-01-04
2025-06-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sucrase-Isomaltase (SI) Genes and Meal Load
NCT07309601
The Effect of Dietary Intervention on Symptoms, Epigenetics, and Gut Microbiota in IBS
NCT03306381
Sucrase-isomaltase Deficiency as a Cause of Irritable Bowel Syndrome
NCT05159115
Comparison Between Low FODMAP and SSRD in IBS
NCT05192603
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will invite patients from this previous study with normal genes and functional variants of genes. The patients will come fasting over night to the department of clinical research. The participants will ingest 75 g sugar dissolved in 0.8 dl water and flavored with lemon, to ingest during 5 minutes. After that, glucose will determined repeatedly up to 2 hours afterwards. At the same time, the participants have to assess their gastrointestinal sympotms on visual analogue scales (VAS).
The investigators will compare the raise in b-glucose and symptoms between the groups of patients, divided into gene expression.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sugar load
Sugar dissolved in water will be ingested during 5 minutes
Sugar
75 g sugar dissolved in 0.8 dl water and flavored with lemon. Ingested during 5 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sugar
75 g sugar dissolved in 0.8 dl water and flavored with lemon. Ingested during 5 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Skane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bodil Ohlsson
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cecilia Kennback, Nurse
Role: STUDY_DIRECTOR
Department of Internal Medicine, Skåne University Hospital, Malmö
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Internal Medicine, Skåne University Hospital
Malmo, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sugarload-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.